| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1821 |
| Trial ID | NCT03355859 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Axi-Cel|Relma-cel|Axicabtagene Ciloleucel|JWCAR029|relmacabtagene autoleucel|Yescarta |
| Location approved | China |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma |
| Year | 2018 |
| Country | China |
| Company sponsor | Ruijin Hospital |
| Other ID(s) | JWCAR029-001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||